PRNewsWire
04 Nov 2025, 21:05 UTC · 46w ago
Verdict
Headline takes no side. We score CHRD +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Chord Energy has raised its full-year 2025 oil volume guidance for the second time this year.
More positive than 78% of claims this week
The company completed the acquisition of XTO assets in October 2025 to extend its inventory runway and improve capital efficiency.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 65% of claims this week
Chord has executed marketing agreements expected to generate between $30 million and $50 million in annualized free cash flow savings.
More positive than 53% of claims this week
Chord declared a base dividend of $1.30 per share and repurchased approximately $83 million in stock during Q3 2025.
So whatConsistent dividends and buybacks are positive for share price support, though these figures are largely in line with a standard return-of-capital strategy.
More positive than 45% of claims this week
The company is bringing back a second completions crew in the fourth quarter of 2025.
More positive than 45% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company reported solid 3Q25 results, raised its full-year oil volume guidance, and successfully completed an acquisition to extend its inventory runway.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
2h ago
+53.2%
Price agrees with the score
$136.27 vs $88.93 close before publication (Nov 4) · not market-adjusted
CHRD chart →
